If future studies provide a direct relationship between tolerant anti-tumor immunity and the acquisition of chemoresistance, it will enhance the opportunity to combat chemoresistance in pancreatic cancer by targeting GSK3β. The gene discussed is GSK3B; the disease is pancreatic neoplasm.